Clinical Trials Logo

Clinical Trial Summary

Induction of insulin secretion by kisspeptin is observed in mouse, pig, rat, and human islets in vitro and in rats, mice and monkeys in vivo, but its mechanism is not fully clear. The present study was designed to investigate the role of KP-10 on insulin secretion in adult healthy and obese men with insulin resistance. The aim of selection of obese persons for the present study was to investigate the effect of acute KP-10 administration in a metabolically challenged condition where the pancreatic beta cells are already highly activated. The long-term objective of this study was to understand the physiological role of kisspeptin signalling in the regulation of insulin secretion in human health and disease.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Kisspeptin Action on Insulin in Healthy Normal Men
  • Kisspeptin Action on Insulin in Obese Diabetic Men

NCT number NCT03771326
Study type Interventional
Source Quaid-e-Azam University
Contact
Status Completed
Phase Phase 3
Start date October 29, 2013
Completion date January 10, 2014